Trial
NCT01962909
Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer
Early Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
University of Virginia
Collaborators
—
Condition
Pancreatic Ductal Adenocarcinoma
Intervention
PTP-01
Why stopped
From preliminary imaging data, the study was stopped due to futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-18